Bayer drops $460M into contraceptive manufacturing sites with the United Nations' backing
Bayer will invest $460 million into two manufacturing sites to expand its production capabilities for contraceptives to low- and middle-income countries.
Through a deal involving the UN Population Fund and the US Agency for International Development, Bayer’s expanding one site in Turku, Finland, and building another in Alajuela, Costa Rica, to produce hormonal implants and intrauterine systems. The investments help Bayer move toward its goal of providing 100 million girls and women with access to family planning by 2030, as well as help boost its commercial supply chain.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,500+ biopharma pros reading Endpoints daily — and it's free.